The Efficacy and Safety of Drug-Coated Balloons in the Treatment of Acute Myocardial Infarction

Du, Mingliang and Hui, Hui (2024) The Efficacy and Safety of Drug-Coated Balloons in the Treatment of Acute Myocardial Infarction. World Journal of Cardiovascular Diseases, 14 (01). pp. 1-9. ISSN 2164-5329

[thumbnail of wjcd_2024010316283891.pdf] Text
wjcd_2024010316283891.pdf - Published Version

Download (306kB)

Abstract

The incidence of acute myocardial infarction (AMI) is increasing year by year, which seriously endangers human health around the world. The preferred treatment strategy for AMI patients is the use of drug-eluting stents (DES), as there is ample evidence to suggest that stent implantation can reduce major adverse cardiovascular events (MACEs). With the application of drug-coated balloons (DCBs) and the enhancement of the concept of interventional without implantation, the question is whether DCBs can be safely and effectively used in patients with AMI? The purpose of this study was to investigate the safety and effectiveness of DCBs in the treatment of AMI. A retrospective review of clinical data was conducted on 55 AMI patients who underwent primary percutaneous coronary intervention (PCI) from January 2020 to December 2021. Of these patients, 25 were treated with DCBs and 30 were treated with DESs. Optical coherence tomography (OCT) was used to measure the minimum lumen diameter, lumen stenosis, and coronary artery dissection before and after surgery, and angina pectoris attacks and various MACEs were recorded at 1, 6, and 12 months after surgery. The results showed that there were no significant differences in clinical baseline data between the two groups. However, the minimum lumen diameter of the DCB group immediately after the operation was smaller than that of the DES group, and the stenosis degree of the lumen in the DCB group was higher than that in the DES group. The incidence of coronary artery dissection in the DCB group was significantly higher than that in the DES group, but the majority of them were type B. At 1, 6, and 12 months after treatment, there was no significant difference in the occurrence of MACEs between the two groups. In conclusion, DCBs is a safe and effective treatment for AMI. However, the incidence of coronary artery dissection in DCB patients is higher than that in DES patients, but the majority of them are type B.

Item Type: Article
Subjects: GO for STM > Multidisciplinary
Depositing User: Unnamed user with email support@goforstm.com
Date Deposited: 06 Jan 2024 09:15
Last Modified: 06 Jan 2024 09:15
URI: http://archive.article4submit.com/id/eprint/2581

Actions (login required)

View Item
View Item